News | March 26, 2022
NATHEALTH 8th annual summit in New Delhi from March 28-29.
More than 120 speakers and 5,000 delegates are expected to attend
More than 120 speakers and 5,000 delegates are expected to attend
Recommendation is based on pivotal data from the phase III POLARIX study
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age
A staggering 65% of the TB cases in India are in the 15-45 age group
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
